Hormone replacement therapy (HRT) does not significantly affect life expectancy, according to updated guidance from the UK’s health assessment body NICE. The guidance includes a new discussion aid to help GPs provide patients with information on HRT and its potential risks and benefits. While HRT may slightly increase the risk of breast cancer and dementia in some cases, it can also reduce the risk of fractures linked to osteoporosis. Overall, the guidance emphasizes that HRT is a beneficial option for managing menopause symptoms, such as hot flushes and night sweats.
The guidance from NICE highlights the importance of considering a woman’s personal situation when deciding on HRT treatment. It notes that while there are some increased risks associated with HRT, it is unlikely to significantly impact overall life expectancy. The guidance also emphasizes the role of talking therapy, such as cognitive behavioural therapy (CBT), in helping women cope with menopause symptoms. This marks a change from previous draft guidelines, which suggested that talking therapy could replace HRT as a treatment.
According to Dr Marie Anne Ledingham, an independent panel assessed scientific evidence to inform the guidance on the risks and benefits of HRT. The risk of conditions such as heart disease, stroke, and certain cancers was found to be comparable among women taking combined HRT and those who had never taken it. However, the risk of breast cancer did show a slight increase in women taking combined HRT for a prolonged period. The guidance aims to provide GPs with easy-to-read illustrations to facilitate informed conversations with patients about the potential risks and benefits of HRT.
Prescriptions for HRT have seen a significant increase in the UK in recent years, indicating a growing awareness of menopause symptoms. However, there is still room for improvement in supporting women from diverse backgrounds who may be unaware of or unable to access treatment options. Professor Jonathan Benger, chief medical officer at NICE, stresses the importance of ensuring that women feel confident in discussing their needs and making informed choices about managing menopause symptoms. Overall, the guidance seeks to provide healthcare professionals with the tools and information needed to support women in navigating their menopause journey.
In conclusion, the updated guidance from NICE on HRT emphasizes the importance of individualized care for women experiencing menopause symptoms. While there are some potential risks associated with HRT, it is generally considered a safe and effective treatment for managing symptoms such as hot flushes and night sweats. The inclusion of talking therapy as a complementary option highlights the holistic approach to menopause care. Moving forward, there is a need to improve access to information and support for women from diverse backgrounds to ensure they have the resources needed to make informed decisions about their health. Ultimately, the goal is to empower women to feel confident in managing their menopause symptoms and overall well-being.
